The 31-GEP Stratifies Risk of Death in Patients with Stage I-IIA Cutaneous Melanoma: A SEER Real-World Evidence Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 4, p. s586, 2025. DOI: 10.25251/ys9mt689. Disponível em: https://skin.dermsquared.com/skin/article/view/3523. Acesso em: 16 nov. 2025.